Interplay between OXA-10 β-lactamase production and low outer-membrane permeability in carbapenem resistance in enterobacterales

UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.grupoInvInvestigación en Microbiología (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issue6es_ES
UDC.journalTitleAntibioticses_ES
UDC.startPage999es_ES
UDC.volume12es_ES
dc.contributor.authorAlonso-García, Isaac
dc.contributor.authorVázquez-Ucha, Juan Carlos
dc.contributor.authorMartínez Guitián, Marta
dc.contributor.authorLasarte-Monterrubio, Cristina
dc.contributor.authorRodríguez-Pallares, Salud
dc.contributor.authorCamacho-Zamora, Pablo
dc.contributor.authorRumbo-Feal, Soraya
dc.contributor.authorAja-Macaya, Pablo
dc.contributor.authorGonzález-Pinto, Lucía
dc.contributor.authorOuteda-García, Michelle
dc.contributor.authorMaceiras, Romina
dc.contributor.authorGuijarro-Sánchez, Paula
dc.contributor.authorMuíño-Andrade, María José
dc.contributor.authorFernández González, Ana
dc.contributor.authorOviaño, Marina
dc.contributor.authorGonzález-Bello, Concepción
dc.contributor.authorArca-Suárez, Jorge
dc.contributor.authorBeceiro Casas, Alejandro
dc.contributor.authorBou, Germán
dc.date.accessioned2025-02-11T09:18:13Z
dc.date.available2025-02-11T09:18:13Z
dc.date.issued2023-06-01
dc.description.abstract[Abstract] The OXA-10 class D β-lactamase has been reported to contribute to carbapenem resistance in non-fermenting Gram-negative bacilli; however, its contribution to carbapenem resistance in Enterobacterales is unknown. In this work, minimum inhibitory concentrations (MICs), whole genome sequencing (WGS), cloning experiments, kinetic assays, molecular modelling studies, and biochemical assays for carbapenemase detection were performed to determine the impact of OXA-10 production on carbapenem resistance in two XDR clinical isolates of Escherichia coli with the carbapenem resistance phenotype (ertapenem resistance). WGS identified the two clinical isolates as belonging to ST57 in close genomic proximity to each other. Additionally, the presence of the blaOXA-10 gene was identified in both isolates, as well as relevant mutations in the genes coding for the OmpC and OmpF porins. Cloning of blaOXA-10 in an E. coli HB4 (OmpC and OmpF-deficient) demonstrated the important contribution of OXA-10 to increased carbapenem MICs when associated with porin deficiency. Kinetic analysis showed that OXA-10 has low carbapenem-hydrolysing activity, but molecular models revealed interactions of this β-lactamase with the carbapenems. OXA-10 was not detected with biochemical tests used in clinical laboratories. In conclusion, the β-lactamase OXA-10 limits the activity of carbapenems in Enterobacterales when combined with low permeability and should be monitored in the future.es_ES
dc.description.sponsorshipThis work was supported by Projects PI20/01212 awarded to A.B., Project PI18/00501 awarded to G.B., and Project PI22/01212 awarded to J.A.-S. within in the National Plan for Scientific Research, Development and Technological Innovation 2017–2020 funded by the Instituto de Salud Carlos III (ISCIII)-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe”. The work was also supported by CIBER-Consorcio Centro de Investigación Biomédica en Red- de Enfermedades Infecciosas, Instituto de Salud Carlos III (CB21/13/00055), Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU and by project IN607A 2020/05 (GAIN-Agencia Gallega de Innovación-Consellería de Economía, Emprego e Industria) awarded to G.B. and project IN607D 2021/12 awarded to A.B. JA-S was financially supported by the Juan Rodés program (ISCIII, JR21/00026), J.C.V.-U. was financially supported by IN606B-2022/009 (Xunta de Galicia), C.L.-M. was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and PI20/01212 (ISCIII), P.G.-S. was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). M.O.-G. was financially supported by IN607D 2021/12. I.A.-G. was financially supported by the Rio Hortega program (ISCIII, CM21/00076). M.M.-G. was financially supported by RSU.UDC.M505 (Ministerio de Universidades). C.G.-B acknowledges financial support from the Spanish Ministry of Science and Innovation (PID2019-105512RB-I00/AEI/10.13039/501100011033), the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03)], and the European Regional Development Fund (ERDF).es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/PI20%2F01212/ES/DESARROLLO Y EVALUACION DE NUEVAS MOLECULAS ANTIMICROBIANAS DIRIGIDAS A PATOGENOS MULTIRRESISTENTES (INHIBIDORES DE ß-LACTAMASAS Y CONJUGADOS TETRACICLINAS-SIDEROFOROS). ESTUDIO NACIONAL ACINETOBACTER SPP.es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/PI18%2F00501/ES/DISEÑO Y DESARROLLO DE UNA VACUNA PARA LA PREVENCION Y ERRADICACION DE LAS INFECCIONES RESPIRATORIAS AGUDAS Y CRONICAS (FIBROSIS QUISTICA) CAUSADAS POR PSEUDOMONAS AERUGINOSAes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia/PI22%2F01212/ES/Inhibidores de carbapenemasas: actividad frente a Enterobacterales productores de carbapenemasas, mecanismos e impacto en la evolución de la resistencia antimicrobiana (PROTECT)es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00055es_ES
dc.description.sponsorshipXunta de Galicia; IN607A 2020/05es_ES
dc.description.sponsorshipXunta de Galicia; IN607D 2021/12es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; JR21/00026es_ES
dc.description.sponsorshipXunta de Galicia; IN606B-2022/009es_ES
dc.description.sponsorshipXunta de Galicia; IN606A-2019/029es_ES
dc.description.sponsorshipXunta de Galicia; IN606A 2021/021es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CM21/00076es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/AEI/Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i/PID2019-105512RB-I00/ES/COMBATIENDO LAS BACTERIAS RESISTENTES A LOS ANTIBIOTICOS Y CONTROLANDO SU EVOLUCION IN VIVO MEDIANTE ESTRATEGIAS INNOVADORAS Y NUEVOS TESTS DE DIAGNOSTICO CLINICOes_ES
dc.identifier.citationAlonso-García I, Vázquez-Ucha JC, Martínez-Guitián M, Lasarte-Monterrubio C, Rodríguez-Pallares S, Camacho-Zamora P, Rumbo-Feal S, Aja-Macaya P, González-Pinto L, Outeda-García M, Maceiras R, Guijarro-Sánchez P, Muíño-Andrade MJ, Fernández-González A, Oviaño M, González-Bello C, Arca-Suárez J, Beceiro A, Bou G. Interplay between OXA-10 β-lactamase production and low outer-membrane permeability in carbapenem resistance in enterobacterales. Antibiotics (Basel). 2023 Jun 1;12(6):999.es_ES
dc.identifier.doi10.3390/antibiotics12060999
dc.identifier.issn2079-6382
dc.identifier.urihttp://hdl.handle.net/2183/41143
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.urihttps://doi.org/10.3390/antibiotics12060999es_ES
dc.rightsCreative Commons Attribution 4.0 International License (CC-BY 4.0)es_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectEnterobacteraleses_ES
dc.subjectOXA-10es_ES
dc.subjectCarbapenem resistancees_ES
dc.titleInterplay between OXA-10 β-lactamase production and low outer-membrane permeability in carbapenem resistance in enterobacteraleses_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Alonso_Interplay_2023.pdf
Size:
1014.96 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Alonso_Interplay_2023_Suppl.pdf
Size:
741.06 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material